CN1871955B - 含纳米材料的卷烟滤嘴制法及该材料在制造香烟中的应用 - Google Patents
含纳米材料的卷烟滤嘴制法及该材料在制造香烟中的应用 Download PDFInfo
- Publication number
- CN1871955B CN1871955B CN2005100731845A CN200510073184A CN1871955B CN 1871955 B CN1871955 B CN 1871955B CN 2005100731845 A CN2005100731845 A CN 2005100731845A CN 200510073184 A CN200510073184 A CN 200510073184A CN 1871955 B CN1871955 B CN 1871955B
- Authority
- CN
- China
- Prior art keywords
- nss
- solution
- nano material
- cigarette
- nanometer selenium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000019504 cigarettes Nutrition 0.000 title claims abstract description 91
- 239000002086 nanomaterial Substances 0.000 title claims abstract description 47
- 238000004519 manufacturing process Methods 0.000 title claims description 27
- 229920006221 acetate fiber Polymers 0.000 claims abstract description 22
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims abstract description 8
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims abstract description 8
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000015921 sodium selenite Nutrition 0.000 claims abstract description 8
- 238000005507 spraying Methods 0.000 claims abstract description 6
- 229960001471 sodium selenite Drugs 0.000 claims abstract description 3
- 239000011781 sodium selenite Substances 0.000 claims abstract description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 49
- 229910052711 selenium Inorganic materials 0.000 claims description 47
- 239000011669 selenium Substances 0.000 claims description 47
- 229940091258 selenium supplement Drugs 0.000 claims description 47
- 238000000034 method Methods 0.000 claims description 45
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims description 28
- 102000004506 Blood Proteins Human genes 0.000 claims description 25
- 108010017384 Blood Proteins Proteins 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 13
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 238000002835 absorbance Methods 0.000 claims description 6
- 230000035484 reaction time Effects 0.000 claims description 6
- 230000004071 biological effect Effects 0.000 claims description 5
- 239000003963 antioxidant agent Substances 0.000 claims description 4
- 230000003078 antioxidant effect Effects 0.000 claims description 4
- 235000006708 antioxidants Nutrition 0.000 claims description 4
- 230000036039 immunity Effects 0.000 claims description 4
- 230000035790 physiological processes and functions Effects 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 3
- 238000002798 spectrophotometry method Methods 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- 102000007562 Serum Albumin Human genes 0.000 abstract 1
- 108010071390 Serum Albumin Proteins 0.000 abstract 1
- 125000005456 glyceride group Chemical group 0.000 abstract 1
- 150000003278 haem Chemical class 0.000 abstract 1
- 238000005096 rolling process Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 31
- 238000012360 testing method Methods 0.000 description 20
- 230000004083 survival effect Effects 0.000 description 15
- 239000000779 smoke Substances 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 11
- 241000699666 Mus <mouse, genus> Species 0.000 description 9
- 230000034994 death Effects 0.000 description 9
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 7
- 239000003546 flue gas Substances 0.000 description 7
- 230000000391 smoking effect Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 6
- 231100000636 lethal dose Toxicity 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 231100000167 toxic agent Toxicity 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 238000011047 acute toxicity test Methods 0.000 description 3
- 230000030833 cell death Effects 0.000 description 3
- 238000005304 joining Methods 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- -1 1.02% Chemical compound 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000000424 bronchial epithelial cell Anatomy 0.000 description 2
- 239000012930 cell culture fluid Substances 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001212149 Cathetus Species 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000035126 Facies Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- 238000007350 electrophilic reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000266 injurious effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
Images
Landscapes
- Cigarettes, Filters, And Manufacturing Of Filters (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005100731845A CN1871955B (zh) | 2005-06-01 | 2005-06-01 | 含纳米材料的卷烟滤嘴制法及该材料在制造香烟中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005100731845A CN1871955B (zh) | 2005-06-01 | 2005-06-01 | 含纳米材料的卷烟滤嘴制法及该材料在制造香烟中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1871955A CN1871955A (zh) | 2006-12-06 |
CN1871955B true CN1871955B (zh) | 2011-09-14 |
Family
ID=37482680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005100731845A Expired - Fee Related CN1871955B (zh) | 2005-06-01 | 2005-06-01 | 含纳米材料的卷烟滤嘴制法及该材料在制造香烟中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1871955B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102406236B (zh) * | 2011-06-27 | 2014-03-26 | 湖北省烟草科研所 | 一种安全性香烟 |
CN105032339B (zh) * | 2015-06-19 | 2018-01-02 | 湖北中烟工业有限责任公司 | 一种用于卷烟降害的硒掺杂纳米二氧化钛吸附材料 |
CN110250564A (zh) * | 2019-05-08 | 2019-09-20 | 中山市博海精细化工有限公司 | 一种含有纳米材料的烟嘴滤嘴制备方法 |
CN110250566A (zh) * | 2019-05-08 | 2019-09-20 | 中山市博海精细化工有限公司 | 一种含有纳米材料的烟嘴滤芯及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1480391A (zh) * | 2002-09-06 | 2004-03-10 | 中国人民解放军军事医学科学院野战输 | 胶体纳米硒颗粒的制备方法 |
CN1554296A (zh) * | 2003-08-25 | 2004-12-15 | 邹剑钢 | 红色纳米硒香烟 |
CN1579263A (zh) * | 2003-08-25 | 2005-02-16 | 邹剑钢 | 纳米硒香烟 |
-
2005
- 2005-06-01 CN CN2005100731845A patent/CN1871955B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1480391A (zh) * | 2002-09-06 | 2004-03-10 | 中国人民解放军军事医学科学院野战输 | 胶体纳米硒颗粒的制备方法 |
CN1554296A (zh) * | 2003-08-25 | 2004-12-15 | 邹剑钢 | 红色纳米硒香烟 |
CN1579263A (zh) * | 2003-08-25 | 2005-02-16 | 邹剑钢 | 纳米硒香烟 |
Also Published As
Publication number | Publication date |
---|---|
CN1871955A (zh) | 2006-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cullen et al. | Bioaccumulation and excretion of arsenic compounds by a marine unicellular alga, Polyphysa peniculus | |
Lourenço et al. | Changes in biochemical profile of Tetraselmis gracilis I. Comparison of two culture media | |
Semenov et al. | Physico-chemical and biological properties of C 60-l-hydroxyproline water solutions | |
Sevindik et al. | Fomitopsis pinicola in healthful dietary approach and their therapeutic potentials | |
Calenic et al. | Oxidative stress and volatile organic compounds: interplay in pulmonary, cardio-vascular, digestive tract systems and cancer | |
CN1871955B (zh) | 含纳米材料的卷烟滤嘴制法及该材料在制造香烟中的应用 | |
Ursache-Oprisan et al. | Sunflower chlorophyll levels after magnetic nanoparticle supply | |
Thorne et al. | Extreme testing of undiluted e-cigarette aerosol in vitro using an Ames air-agar-interface technique | |
CN105439782B (zh) | 癸二醇作为硝化抑制剂的应用 | |
Aghajanyan et al. | Silver ion bioreduction in nanoparticles using Artemisia annua L. extract: Characterization and application as antibacterial agents | |
Lam et al. | Growth interactions among blue-green (Anabaena oscillarioides, Microcystis aeruginosa) and green (Chlorella sp.) algae | |
Naeem et al. | Brassinosteroid-mediated enrichment in yield attributes, active constituents and essential oil production in Mentha arvensis L. | |
Idrees et al. | Effects of gamma-irradiated sodium alginate on lemongrass: Field trials monitoring production of essential oil | |
Kováčik et al. | Nitrogen nutrition modulates oxidative stress and metabolite production in Hypericum perforatum | |
Lin et al. | Soil metagenomic analysis on changes of functional genes and microorganisms involved in nitrogen-cycle processes of acidified tea soils | |
Cochlan et al. | Kinetics of nitrogen (nitrate, ammonium and urea) uptake by the picoflagellate Micromonas pusilla (Prasinophyceae) | |
CN106333947B (zh) | 表小檗碱在制备脲酶抑制剂中的应用 | |
Sabaratnam et al. | Effects of nitrogen dioxide on leaf chlorophyll and nitrogen content of soybean | |
Halterman et al. | Kinetics of nitrate uptake by freshwater algae | |
Sideris et al. | Pineapple chlorosis in relation to iron and nitrogen | |
Rejmánková et al. | Response of root and sediment phosphatase activity to increased nutrients and salinity | |
Li et al. | Impacts of elevated pCO2 on trace gas emissions in two microalgae: Phaeocystis globosa and Nitzschia closterium | |
Deng et al. | Selenium speciation in ginger using capillary electrophoresis online coupled with electrothermal atomic absorption spectrometry | |
Martins et al. | Soil microbial attributes under agroforestry systems in the cerrado of Minas Gerais | |
Xue et al. | The energetics of extracellular Fe (III) reduction by iron‐limited Chlamydomonas reinhardtii (Chlorophyta) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: OMEGA BIOTECH (SHANGHAI) CO., LTD. Free format text: FORMER OWNER: CHINA WEIHU CO., LTD. Effective date: 20121009 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: MACAU, CHINA TO: 201210 PUDONG NEW AREA, SHANGHAI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20121009 Address after: 201210, F3, Mianyang North Road, Zhangjiang Town, Shanghai, Pudong New Area, 185 Patentee after: Omega Biotech Shanghai Co., Ltd. Address before: The Macao Special Administrative Region China luoliji Road No. 223-225 Building 8 floor, room 809 South Patentee before: China Weihu Co., Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20200327 Address after: 237000 Shouxian County Road, Lu'an economic and Technological Development Zone, Anhui Patentee after: AOGE BIOTECHNOLOGY (LU'AN) Co.,Ltd. Address before: 201210, F3, Mianyang North Road, Zhangjiang Town, Shanghai, Pudong New Area, 185 Patentee before: OMEGA BIOTECH SHANGHAI Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110914 Termination date: 20200601 |
|
CF01 | Termination of patent right due to non-payment of annual fee |